发明名称 |
Nasal drug products and methods of their use |
摘要 |
Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided. |
申请公布号 |
US9211253(B2) |
申请公布日期 |
2015.12.15 |
申请号 |
US201514659472 |
申请日期 |
2015.03.16 |
申请人 |
Lightlake Therapeutics Inc. |
发明人 |
Crystal Roger;Weiss Michael Brenner |
分类号 |
A61M31/00;A61M5/00;A61F13/00;A61K31/56;A61K9/00;A61K31/485;A61K47/02;A61K47/18;A61K9/08;A61M11/02;A61M15/08 |
主分类号 |
A61M31/00 |
代理机构 |
|
代理人 |
Bennett Dennis A. |
主权项 |
1. A single-use, pre-primed device adapted for nasal delivery of a pharmaceutical composition to a patient by one actuation of said device into one nostril of said patient, having a single reservoir comprising a pharmaceutical composition which is an aqueous solution of about 100 μL comprising:
about 4 mg naloxone hydrochloride or a hydrate thereof; between about 0.2 mg and about 1.2 mg of an isotonicity agent; between about 0.005 mg and about 0.015 mg of a preservative; about 0.2 mg of a stabilizing agent; an amount of an acid sufficient to achieve a pH or 3.5-5.5. |
地址 |
New York NY US |